1. Home
  2. BDC vs CORT Comparison

BDC vs CORT Comparison

Compare BDC & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Belden Inc

BDC

Belden Inc

HOLD

Current Price

$113.40

Market Cap

5.6B

ML Signal

HOLD

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$33.23

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDC
CORT
Founded
1902
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
3.7B
IPO Year
1994
2001

Fundamental Metrics

Financial Performance
Metric
BDC
CORT
Price
$113.40
$33.23
Analyst Decision
Strong Buy
Buy
Analyst Count
3
6
Target Price
$148.33
$105.20
AVG Volume (30 Days)
296.5K
1.6M
Earning Date
04-30-2026
05-04-2026
Dividend Yield
0.18%
N/A
EPS Growth
23.13
N/A
EPS
5.91
0.82
Revenue
$2,715,194,000.00
$761,407,000.00
Revenue This Year
$8.80
$29.97
Revenue Next Year
$4.67
$30.25
P/E Ratio
$19.23
$40.73
Revenue Growth
10.33
12.79
52 Week Low
$83.18
$28.66
52 Week High
$159.99
$117.33

Technical Indicators

Market Signals
Indicator
BDC
CORT
Relative Strength Index (RSI) 29.17 37.40
Support Level $107.97 $28.66
Resistance Level $125.01 $41.92
Average True Range (ATR) 4.54 1.26
MACD -2.91 0.29
Stochastic Oscillator 0.83 35.65

Price Performance

Historical Comparison
BDC
CORT

About BDC Belden Inc

Belden Inc is a supplier of complete connection solutions. It has two segments, Smart Infrastructure Solutions and Automation Solutions. Smart Infrastructure Solutions provides network infrastructure and broadband solutions, serving markets such as data centers, government, healthcare, and broadband and wireless service providers, with products including copper and fiber cable and connectivity solutions. Automation Solutions provides digitization and automation solutions that enable IT OT convergence and support acquisition, transmission, orchestration, and management, serving markets including Warehousing and Logistics, Energy, Transportation, and Discrete Manufacturing. The company operates in the Americas, EMEA, and APAC, with maximum revenue coming from the Americas.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Share on Social Networks: